Skip to main content

Cardiogenic Shock in Advanced Heart Failure: Device Options and A Team Approach

Jerry D. Estep, MD, FACC, FASE
Associate Professor of Clinical Medicine Section Head of Heart Transplant and Mechanical Circulatory Support, Division of Heart Failure Medical Director, Heart Transplant & LVAD Program


The use of temporary percutaneous mechanical circulatory support (MCS) is part of the treatment armamentarium for treating high-risk patients for acute coronary syndrome (ACS). Cardiogenic shock can complicate other conditions, including chronic progressive heart failure. Given mortality rates in CS remain unacceptable high, the use of temporary MCS should be considered early in a patient’s clinical course. The purpose of this session is to share an expert’s experience on utilizing the team approach in recognizing shock early and intervening rapidly in the management of patients in acutely decompensated failure.

Learning objectives

  1. Review the spectrum of cardiogenic shock and available temporary mechanical circulatory support options
  2. Identify key hemodynamic parameters to evaluate patient response to treatment strategies
  3. Describe real world experience when treating the advanced heart failure patient
Back to Top